Skip to main content

Table 1 Radiological and molecular characteristics of patients

From: Performance of 18 F-FAPI PET/CT in assessing glioblastoma before radiotherapy: a pilot study

Pt

Age, yr/Sex

Lesions (MRI)

Lesions (FAPI)

TBR

SUVmax

Ki-67 index (%)

MGMT

TERT

IDH

1

48/M

4

1

16.76#

7.88

30

+

+

2

48/M

1

1

8.28#

7.52

60

+

3

59/M

1

1

19.21#

8.32

20

+

4

58/F

4

3

9.43#

7.99

40

+

19.56

2.82

N/A

N/A

N/A

N/A

22.03

3.48

N/A

N/A

N/A

N/A

5

34/F

1

1

8.88#

6.82

10

+

+

6

56/F

4

1

26.59#

8.64

50

+

7

48/F

2

2

10.98#

7.20

80

+

21.05

1.94

N/A

N/A

N/A

N/A

8

36/F

1

1

61.69#

8.27

60

+

9

73/M

1

1

27.38#

8.63

20

+

+

10

58/M

1

1

13.06#

7.50

70

+

11

49/F

2

2

7.90#

3.41

35

+

+

16.19

5.49

N/A

N/A

N/A

N/A

12

55/M

1

1

30.21#

17.34

40

+

Total

 

23

16

19.95 ± 13.22

7.08 ± 3.55

    
  1. Pt, patient; MGMT: MGMT promoter methylation; TERT: TERT mutation; IDH:IDH mutation; #: specimen undergoing biopsy or surgical resection for immunohistochemistry, and molecular expression